Clinical Trials Browser

Phase 1/2 × COVID-19 × 30 days × Clear all

NCT04565665 2026-03-10

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase 1/2 Recruiting

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms